Reassessing the Process of Drug Development for Duchenne Muscular Dystrophy: Dongzhe Hong, PhD
February 13th 2024The postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School discussed some of the issues with ensuring timely care access to approved therapies for patients with Duchenne muscular dystrophy. [WATCH TIME: 3 minutes]